ALKALINE WATER Co INC (WTER): Nasdaq/NYSE listing notice — Alkaline Water Co. receives Nasdaq delisting notice for late Form 10-K filing

ALKALINE WATER Co INC

Received Nasdaq deficiency letter on July 18, 2023 for failure to file annual report (Form 10-K) for fiscal year ended March 31, 2023.
Company has 60 days (until September 18, 2023) to submit a compliance plan under Listing Rule 5250(c)(1).
If plan accepted, Nasdaq may grant up to 180 days from Form 10-K due date, to January 10, 2024, to regain compliance.
No assurance of regaining compliance; if delisted, common stock may trade on OTC Markets Group.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ALKALINE WATER Co INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

July 18, 2023, The Alkaline Water Company Inc. (the "Company") received a deficiency letter (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market (the "Nasdaq"), notifying the Company that since the Company had not yet filed its Form 10-K for the year ended March 31, 2023 (the "Form 10-K"), it no longer complies with the Nasdaq's Listing Rule 5250(c)(1) (the "Rule") relating to the Company's obligation to file periodic financial reports for continued listing. The Letter stated that the Company has 60 calendar days to submit a plan (the "Plan") to regain complianc

View on SEC.gov

Browse all listing & compliance notices →

ALKALINE WATER Co INC filing history →

Source: SEC EDGAR

accession 0001062993-23-015157

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.